FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4377018051> ?p ?o ?g. }

• W4377018051 endingPage "181" @default.
• W4377018051 startingPage "175" @default.
• W4377018051 abstract "Objectives This study aimed to evaluate the cost-effectiveness of niraparib versus routine surveillance as maintenance therapy for patients with platinum-sensitive recurrent ovarian cancer in China. Method A three-state partitioned survival model that adopted a lifetime horizon with a 4-week cycle length was developed. Efficacy data were derived from the NORA study. Cost and utility data were obtained from published studies and online databases. The cost and health outcomes were discounted at an annual rate of 5%. In this analysis, the primary outcomes included quality-adjusted life-year (QALY) and incremental cost-effectiveness ratio (ICER). The willingness-to-pay (WTP) thresholds were set at 1 to 3 times the gross domestic product per capita of China in 2022 ($12,741 to $38,233/QALY). Sensitivity analyses were conducted to verify the robustness of the model results. Results In the base-case analysis, niraparib was not found to be cost-effective, with an ICER of $42,888/QALY compared with routine surveillance at the WTP thresholds. One-way deterministic sensitivity analyses indicated that the ICER value was most sensitive to the cost of subsequent treatment in placebo group. The probabilistic sensitivity analysis suggested that at the WTP thresholds, the probability of niraparib being cost-effective was 2.9% to 50.1%. Conclusions Niraparib improves the survival benefit of platinum-sensitive recurrent ovarian cancer patients. However, it seems to be less cost-effective, as it has higher costs than routine surveillance at the WTP thresholds. Reasonable dose reduction according to the patient's actual situation or lowering the price of niraparib can improve its cost-effectiveness." @default.
• W4377018051 created "2023-05-19" @default.
• W4377018051 creator A5019857232 @default.
• W4377018051 creator A5040533308 @default.
• W4377018051 creator A5055623523 @default.
• W4377018051 creator A5078824721 @default.
• W4377018051 date "2023-07-01" @default.
• W4377018051 modified "2023-09-26" @default.
• W4377018051 title "Cost-effectiveness analysis of niraparib maintenance therapy in Chinese patients with platinum-sensitive recurrent ovarian cancer" @default.
• W4377018051 cites W1982967337 @default.
• W4377018051 cites W2122624385 @default.
• W4377018051 cites W2130078242 @default.
• W4377018051 cites W2528228811 @default.
• W4377018051 cites W2737389832 @default.
• W4377018051 cites W2754327139 @default.
• W4377018051 cites W2793221647 @default.
• W4377018051 cites W2884001607 @default.
• W4377018051 cites W2885812853 @default.
• W4377018051 cites W2902886329 @default.
• W4377018051 cites W2918165099 @default.
• W4377018051 cites W2925017121 @default.
• W4377018051 cites W2943415606 @default.
• W4377018051 cites W2969972205 @default.
• W4377018051 cites W3002796847 @default.
• W4377018051 cites W3120953566 @default.
• W4377018051 cites W3128646645 @default.
• W4377018051 cites W3178585484 @default.
• W4377018051 cites W3186637506 @default.
• W4377018051 cites W4200127049 @default.
• W4377018051 cites W4205387561 @default.
• W4377018051 cites W4220916058 @default.
• W4377018051 cites W4224951890 @default.
• W4377018051 cites W4291158287 @default.
• W4377018051 cites W4295008632 @default.
• W4377018051 cites W4313334428 @default.
• W4377018051 doi "https://doi.org/10.1016/j.ygyno.2023.05.010" @default.
• W4377018051 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37209503" @default.
• W4377018051 hasPublicationYear "2023" @default.
• W4377018051 type Work @default.
• W4377018051 citedByCount "0" @default.
• W4377018051 crossrefType "journal-article" @default.
• W4377018051 hasAuthorship W4377018051A5019857232 @default.
• W4377018051 hasAuthorship W4377018051A5040533308 @default.
• W4377018051 hasAuthorship W4377018051A5055623523 @default.
• W4377018051 hasAuthorship W4377018051A5078824721 @default.
• W4377018051 hasConcept C112930515 @default.
• W4377018051 hasConcept C121608353 @default.
• W4377018051 hasConcept C126322002 @default.
• W4377018051 hasConcept C143998085 @default.
• W4377018051 hasConcept C162324750 @default.
• W4377018051 hasConcept C175444787 @default.
• W4377018051 hasConcept C184834754 @default.
• W4377018051 hasConcept C2777364431 @default.
• W4377018051 hasConcept C2780427987 @default.
• W4377018051 hasConcept C29456083 @default.
• W4377018051 hasConcept C3019080777 @default.
• W4377018051 hasConcept C71924100 @default.
• W4377018051 hasConceptScore W4377018051C112930515 @default.
• W4377018051 hasConceptScore W4377018051C121608353 @default.
• W4377018051 hasConceptScore W4377018051C126322002 @default.
• W4377018051 hasConceptScore W4377018051C143998085 @default.
• W4377018051 hasConceptScore W4377018051C162324750 @default.
• W4377018051 hasConceptScore W4377018051C175444787 @default.
• W4377018051 hasConceptScore W4377018051C184834754 @default.
• W4377018051 hasConceptScore W4377018051C2777364431 @default.
• W4377018051 hasConceptScore W4377018051C2780427987 @default.
• W4377018051 hasConceptScore W4377018051C29456083 @default.
• W4377018051 hasConceptScore W4377018051C3019080777 @default.
• W4377018051 hasConceptScore W4377018051C71924100 @default.
• W4377018051 hasLocation W43770180511 @default.
• W4377018051 hasLocation W43770180512 @default.
• W4377018051 hasOpenAccess W4377018051 @default.
• W4377018051 hasPrimaryLocation W43770180511 @default.
• W4377018051 hasRelatedWork W2049601234 @default.
• W4377018051 hasRelatedWork W2144702115 @default.
• W4377018051 hasRelatedWork W2147873611 @default.
• W4377018051 hasRelatedWork W2896984381 @default.
• W4377018051 hasRelatedWork W2942643371 @default.
• W4377018051 hasRelatedWork W3004507055 @default.
• W4377018051 hasRelatedWork W3004977548 @default.
• W4377018051 hasRelatedWork W3032543802 @default.
• W4377018051 hasRelatedWork W3112863407 @default.
• W4377018051 hasRelatedWork W4321602043 @default.
• W4377018051 hasVolume "174" @default.
• W4377018051 isParatext "false" @default.
• W4377018051 isRetracted "false" @default.
• W4377018051 workType "article" @default.